Edwards Lifesciences Corporation Common Stock vs Navan Inc. Class A Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Navan Inc. Class A Common Stock trades at $23.16 (market cap $5.80B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 8.5× Navan Inc. Class A Common Stock's market cap, and Navan Inc. Class A Common Stock is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | NAVN | |
|---|---|---|
Market Cap | $49.44B | $5.80B |
Volume | 3,508,027 | 3,022,922 |
Sector | Health | Technology |
52-Week High | $95.18 | $30.58 |
52-Week Low | $72.65 | $8.51 |
Enterprise Value | $45.90B | $5.15B |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →